^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ERAS-801

    i
    Other names: ERAS-801
    Company:
    Erasca, Katmai Pharma
    Drug class:
    EGFR inhibitor
    Related drugs:
    10ms
    A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1) (clinicaltrials.gov)
    P1, N=52, Active, not recruiting, Erasca, Inc. | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    IDH wild-type
    |
    ERAS-801